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Abstract
To perform clinical analysis of the effectiveness of the complex treatment of occlusive vascular diseases and
fungal lesions of feet with addition of local antifungal medicines.
Materials and Methods. The results of examination and treatment of five patients with obliterating diseases of
the lower limb vessels and diabetes mellitus with dermatomycosis and onychomycosis of the feet were analyzed.
Onychomycosis or mycosis of feet were treated with the help of the combination of the following antifungal
creams was used in the treatment: miconazole, clotrimazole, tioconazole in a ratio of 1:1:6.5 contained in the
combined preparation cream ”XaTonic”.
Results and discussion. The use of an antifungal mixture of creams after 7 days has led to the disappearance of
the clinical manifestations of dermatomycosis of the feet in three patients, and in two patients with onychomycosis
after 14 days there was the reduction of clinical symptoms.
Conclusions. The combination of three local antifungal components: miconazole, clotrimazole, thioconazole is
effective in treatment of dermatomycosis of the feet. In the treatment of fungal lesions of the feet by dermatologists
in patients aged after fifty years, an angiologist/vascular surgeon’s consultation is required.
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Problem statement and analysis of
the latest research
Fungal lesions of the feet and nails are a concomi-
tant disorder of peripheral arterial diseases of the
lower extremities. Fungal lesions of the feet happen
nine times more likely in patients with obliterating
diseases of arteries of the lower extremities and 175
times more likely in patients with diabetic angiopa-
thy of the lower extremities compared to healthy
people [1, 2]. It was found that onychomycosis is an
early manifestation of the vascular lesion, and the
reduction of the ankle-brachial index statistically
correlates with onychomycosis [2]. The presence
of onychomycosis significantly increases the risk
of development of diabetic ulcers in patients with
diabetes mellitus [3]. Dermatomycosis and ony-
chomycosis are difficult to treat in patients with
the obliterating diseases of peripheral vessels of the
feet [4]. In combination of diabetes mellitus, obe-
sity, hypertension with the damage of peripheral
vessels of the lower limbs there are the major risk
factors for development of fungal infections of the
feet and nails. That is why it is recommended to
treat onychomycosis with the help of oral antifun-
gal medicines [5]. These drugs have a high level
of hepatotoxicity, and quite often may lead to gas-
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trointestinal disorders and other complications [5].
The fungal skin lesions and onychomycosis may
create the source for pathogenic microflora, which
delays healing of postoperative wounds, ulcers, and
necrotic process also may progress in diabetic foot
syndrome [3].
Objective. To perform a clinical analysis of
the effectiveness of the combination of the local
antifungal treatment for dermatomycosis and ony-
chomycosis of the feet in patients with occlusal
vascular diseases.
1. Materials and Methods
There were five patients with fungal lesions of the
feet and nails under our supervision. There were
three patients with obliterating arterial atherosclero-
sis of IIa degree (according to the classification of
Fontaine) and two patients with obliterating arterial
atherosclerosis of IIb degree and type II diabetes
mellitus. The characteristics of patients is shown in
Table 1.
The patient M. had had diabetes mellitus for
8 years. The level of glycosylated hemoglobin
(HbA1) was 7.5% at the moment of examination.
According to the classification of the compensation
degree of carbohydrate metabolism in the patient
M., there was decompensated form of diabetes mel-
litus and moderate (II degree) of the severity of
diabetes mellitus. The femoral and popliteal arter-
ies were stenosed from 20 to 50%. The anterior and
posterior tibial arteries were stenosed at 50-75%.
The patient Ya. had had diabetes for 15 years.
The level of glycosylated hemoglobin (HbA1) was
8.1% at the moment of study. According to the
classification of the degree of compensation of car-
bohydrate metabolism in the patient Ya., there was a
decompensated form of diabetes mellitus and mod-
erate (II degree) severity of diabetes mellitus. The
femoral artery was stenosed from 20 to 50%. The
popliteal, anterior and posterior tibial arteries were
stenosed at 50-75%.
In all patients (patients B., S., V.) without dia-
betes mellitus, stenosis of the femoral and popliteal
arteries was from 20 to 50%. The anterior and pos-
terior tibial arteries in all patients were stenosed
within 50-75%.
The ankle-brachial index (ABI) was measured
in the supine position using a portable vascular
doppler ”Sonoline” with a frequency of 8 MHz.
We applied a blood pressure cuff on the shoulder
and air was inflated until the blood flow in the shoul-
der artery disappeared, then air was slowly released
and the pressure was noted when the blood flow
appeared again. Thereafter, the procedure was re-
peated on the calf, which was symptomatic during
walking. The lowest measurement of blood pres-
sure was detected on the posterior tibial artery and
dorsalis pedis artery. Then, the ratio between the
systolic blood pressure on the lower extremities to
the systolic blood pressure on the upper extremities
was calculated. Because of the fact that in patients
with diabetes mellitus the ABI was successfully de-
termined with the use of this method, we haven’t
measured the toe-brachial index.
The most common pathogens of dermatomyco-
sis and onychomycosis are Trichophyton rubrum
and Candida parapsilosis, accounting for about 85-
90% of all possible causes [9, 10]. These pathogens
are sensitive to the topical local antifungal drugs
such as miconazole, clotrimazole, and tioconazole,
which were used in this study. In this regard, we’ve
treated patients empirically and did not identify spe-
cific agents of mycotic infection.
the patients were performed an ultrasound du-
plex scanning of the lower extremities’ arteries with
the determination of their stenosis by identifying the
peak systolic blood flow velocity (PSV, cm/sec). We
considered that stenosis of arteries ranged from 20
to 50% if the PSV ranging from 150 to 200 cm/sec.
At PSV from 200 to 300 cm/sec the stenosis of
arteries ranged from 50 to 75%.
Onychomycosis or mycosis of feet was treated
locally with the help of a combination of the topical
anti-fungal creams of wide spectrum of action: mi-
conazole (2% cream, manufacturer of PJSC ”Phar-
maceutical firm ”Darnytsa”, Ukraine), clotrima-
zole (1% cream, manufacturer PJSC ”FITOFARM”,
Ukraine), tioconazole (1% cream, manufacturer
PFIZER, USA) in a ratio of 1:1:6.5. This com-
bination was used because of the reporting of the ef-
fectivity of the medicine ”XaTonic” for onychomy-
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Table 1. Characteristics of patients before admission to the hospital
Sex Age,
years
Type 2
dia-
betes,
yes / no
Ankle-
brachial
index
Blood
pres-
sure,
mmHg
Type of fungal lesion Stage
according to
Fontaine
classification
Patient B., male 67 no 0.62 160/95 Bilateral feet mycosis IIa
Patient S., male 65 no 0.73 140/90 Bilateral feet mycosis IIa
Patient V., male 61 no 0.75 130/85 Bilateral feet mycosis IIa
Patient Ya., male 63 yes 0.58 150/90 Bilateral onychomyco-
sis and feet mycosis
IIb
Patient M., male 66 yes 0.69 165/90 Bilateral onychomyco-
sis and feet mycosis
IIb
cosis (manufacturer PUNCH Skin Care, USA) [6],
which is not registered in Ukraine.
The patients were explained how to prepare a
leg before application of a mixture of antifungal
creams (washing of the feet with warm water and
soap, safe removal of part of the affected nail, clean-
ing of the outer surface of the nail plate and nail
bed, clearing the gaps between the fingers). Creams
were applied to the feet, nail beds and plates twice a
day, and carefully rubbed into the folds of the skin.
in the process of the complex treatment, there
were appointed consultations of other specialists
(cardiologist, endocrinologist) and administered ap-
propriate therapy for diabetes mellitus, hyperten-
sion and coronary heart disease, as well as anti-
aggregate therapy (cilostazol) as one of the main
directions of the obliterating atherosclerosis treat-
ment of the vessels of the lower extremities.
Treatment results were evaluated by ad oculus,
as well as by the presence or absence of symptoms
of dermatomycosis.
2. Results and Discussion
After 7 days of complex treatment with the use of
the mixture of creams in two patients (patients B.
and S.), there was the complete disappearance of
clinical manifestations of dermatomycosis on the
feet (Fig. 1), and in one patient there was a signif-
icant improvement on the skin and the absence of
any symptoms of the iiritation (patient B.).
Figure 1. The appearance of the affected by
dermatomycosis foot in patient B., before (on the
left side) and after (seven days of treatment on the
right side) with the mixture of creams twice a day.
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Figure 2. The appearance of the affected by
dermatomycosis and onychomycosis foot in patient
Ya., before (on the left side) and after 14 days of
treatment (on the right side)with the mixture of
creams twice a day.
However, in patients Ya., and M., with ony-
chomycosis after 14 days of treatment, there was
improvement only on the affected skin, while the
nails were still affected (Fig. 2). Irritation symp-
toms have decreased significantly.
All patients have a warm feeling and pleasant
slight tingling in the area of feet during the use of
the combination of creams. The number of symp-
toms of irritation (itching, burning sensation, etc.)
decreased in all patients. Side effects were absent
in all patients. Unfortunately, after the discharge
from the hospital, the connection with all patients
was lost.
3. Prospects of Further
Researches
The weak effect of the complex treatment with
antifungal drugs in patients with onychomycosis
may be explained by poor penetration of active sub-
stances under the nail bed and into the area of nail
plate growth. Also, the growth rate of the nail on the
lower extremity is 1.67 mm per month in healthy
people [7]. That is why it can be concluded that
the complete renewal of the nail on the lower limb
is on average six months. By the way, the epider-
mis of the skin is completely renewed in about 1.5
months [8]. This means that by increasing the du-
ration of treatment at least 4-fold (minimum, up
to 28 days) may reveal the effectiveness of treat-
ment with topical antifungal drugs in patients with
onychomycosis.
4. Conclusions
The combination of three topical antifungal drugs
for seven days (miconazole, clotrimazole, tiocona-
zole) was effective for treatment of the skin der-
matomycosis on the feet in three patients with the
occlusal diseases of the arteries of the II degree.
The combination of three local antifungal com-
ponents for 14 days (miconazole, clotrimazole, ti-
oconazole) was not so effective for the treatment
of onychomycosis in two patients with the occlusal
diseases of the arteries of the II degree and type 2
diabetes mellitus.
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